Geode Capital Management »

Celldex Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $28M 1.0M 27.52
2023-06-30 $33M 965k 33.93
2023-03-31 $33M 926k 35.98
2022-12-31 $39M 884k 44.57
2022-09-30 $24M 853k 28.11
2022-06-30 $23M 841k 26.96
2022-03-31 $29M 856k 34.06
2021-12-31 $31M 810k 38.64
2021-09-30 $43M 793k 53.99
2021-06-30 $23M 673k 33.44
2021-03-31 $7.3M 353k 20.60
2020-12-31 $5.2M 299k 17.52
2020-09-30 $3.8M 258k 14.83
2020-06-30 $1.7M 130k 13.00
2020-03-31 $172k 104k 1.65
2019-12-31 $231k 104k 2.22
2019-09-30 $219k 103k 2.12
2019-06-30 $276k 103k 2.67
2019-03-31 $532k 108k 4.91